Davidson Kempner Capital Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,252,001
Closed -$96.5M 312
2023
Q4
$96.5M Buy
+3,252,001
New +$64.8M 1.47% 15

Other funds holding IMGN

Davidson Kempner Capital Management's IMGN Position: Q1 2024 in Review

Davidson Kempner Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 3,252,001 shares — an estimated $96.5M sold.

Davidson Kempner Capital Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $96.5M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Davidson Kempner Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 3,252,001 Immunogen Inc shares in Q1 2024, an estimated $96.5M.
  • Davidson Kempner Capital Management first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Immunogen Inc position peaked at $96.5M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2024, filed 15 May 2024.